Quest Diagnostics 2015 Annual Report Download - page 16

12
laboratories to develop and perform a broad menu of esoteric tests, or to perform low-volume esoteric testing in-house. Such
tests generally are outsourced to an esoteric clinical testing laboratory, which specializes in performing these complex tests.
Commonly ordered esoteric tests include viral and bacterial detection tests, drug therapy monitoring tests, gene-based tests,
autoimmune panels and complex cancer evaluations. Esoteric tests increasingly are ordered by physicians to assist them in the
diagnostic process, to establish a prognosis and to choose or monitor a therapeutic regimen.
Anatomic pathology services are performed on tissues, such as biopsies, and other samples, such as human cells.
Anatomic pathology involves the diagnosis of cancer and other diseases and medical conditions through examination of tissue
and cell samples taken from patients.
Our services.
We are the world's largest provider of diagnostic information services. We provide information and insights based on
clinical testing, including routine, esoteric, gene-based and anatomic pathology testing, and related services. Increasingly, we
are focused on providing solutions and insights to our customers, based on the testing that we perform and our extensive
information and connectivity assets.
We are the leading provider of routine, esoteric and gene-based and anatomic pathology testing in the world, and offer
customers the broadest access to the most extensive test menu. We are a leading provider of infectious disease diagnostic
information services and strive to be the first to provide diagnostic solutions for emerging infectious diseases, including our
Focus Diagnostics® offerings for West Nile Virus, SARS and Influenza A H1N1. We have leading positions in the neurology
diagnostics market, in advanced cardiovascular diagnostic information services, including our CardioIQ® offering, and in
cancer diagnostics, including the BRCAVantage®, OncoVantage® and ColoVantage® offerings. We are a leader in providing
testing for the detection of employee use of drugs of abuse, offering a full range of solutions, including urine, hair, blood and
oral fluid tests.
We also are a leading provider of biometric wellness screenings, flu shots and related preventative services that
leverage clinical data to improve population health outcomes and reduce healthcare spend. We offer biometric wellness
screenings to employer populations through our patient service centers and on-site through our extensive network of mobile
examiners and nurses. In addition to a wide range of screening options, we also offer Blueprint for Wellness® and private label
reporting, analytics and incentive management services. These services are sold directly to employers and through reseller
partnerships with many health plans
We have significant information assets, including many years of test result data, and we are focused on ways to
leverage the full power of these assets to help our customers. We also have a history of providing leading information
technology for diagnostic information services. To help our customers empower better health through diagnostic insights by
taking advantage of our information assets and technology prowess, we offer QuanumTM health information technology
solutions. We believe that our QuanumTM solutions, including those introduced in 2015 and listed in Table 14 on page 10,
promote our strategy, enhance the value we provide to our customers and will result in increased customer loyalty. We are
working on health information technology solutions designed to:
• enhance the customer experience, including ease of use and patient and provider engagement;
• deliver more precise, comprehensive solutions and actionable information;
• provide increased and interactive insights and analytics to patients and providers;
• foster greater adherence to clinical and reimbursement guidelines;
• promote population health solutions;
• tap the potential of large amounts of clinical information; and
• advance the development of precision medicine.
We believe that offering services, solutions and insights based on a full range of tests and information assets will
strengthen our market offering, market position and reputation. Our experienced medical staff has a passion for providing the
highest quality service to our customers. Our in-house experts, including medical directors, scientific directors, genetic
counselors and board certified geneticists, provide medical and scientific consultation regarding our tests and test results, and
help clinicians and others best utilize these tests to improve patient outcomes and enhance patient satisfaction. Our approach
fosters personalized patient care.
We have built advanced testing capabilities, including gene-based testing services for the predisposition, diagnosis,
treatment and monitoring of cancers and other diseases. We provide integrated, comprehensive diagnostic information services
QUEST DIAGNOSTICS 2015 ANNUAL REPORT ON FORM 10-K